Poster # 3013 Clinical Trials Review: Molecular Targeted Agents In Combination With Radiotherapy In Solid Tumors - A Pharmaceutical Industry Perspective

Presenter: Ozlem Ataman, MD, PhD

About the Presenter:
A senior doctor of medicine with more than 10 years of clinical experience in radiation/clinical oncology. Research background leading to a PhD award from University College London in oncology clinical outcomes,competing risks analysis and correlation with molecular markers. Clinical lead for ROCKIT (Radiation Oncology Combinations Key Implementation Team) since 2009 working cross-functional with many teams building and leading radiotherapy combinations strategy at AstraZeneca. Five years pharmaceutical research experience in early and late phase drug development.
Contact the presenter at: ozlem.ataman@astrazeneca.com

Abstract:


E-mail a friend about this poster:
Enter email address: